ADVFN US – Market Content Editor
-
Medicus Pharma Identifies 200 µg SkinJect Patch as Lead Development Dose After Phase 2 Study
The completed SKNJCT-003 study is shaping Medicus Pharma’s next clinical strategy, with the 200 µg dose moving into an FDA-authorized Gorlin syndrome program while the company considers partnerships for nodular basal cell carcinoma. Key Investor Takeaways Why MDCX Stock Is in Focus Medicus Pharma has published an abridged final Clinical Study Report for its Phase…
-
1-800-FLOWERS.COM Reports Revenue Decline as Company Evaluates Capital Raising Options
Fiscal 2026 revenue fell 10.8% to $1.50 billion and adjusted EBITDA declined to $2.9 million, while the company amended its credit agreement and began reviewing financing and asset-sale alternatives. Key Investor Takeaways Why FLWS Stock Is in Focus 1-800-FLOWERS.COM reported lower fiscal 2026 revenue and adjusted profitability while outlining measures intended to provide additional financial…
-
Roche’s Genentech Gets FDA Priority Review for Enspryng in MOGAD
The FDA is expected to decide by January 10, 2027, after a Phase III study showed Enspryng reduced the risk of MOGAD relapse by 68% versus placebo. Key Investor Takeaways Why RHHBY Stock Is in Focus The FDA granted Priority Review to Genentech’s application seeking to expand Enspryng into myelin oligodendrocyte glycoprotein antibody-associated disease, or…
-
Medical Care Technologies Configures StrainScan Pro AI Vision Modules for High-Value Produce
StrainScan Pro is being tailored for leafy greens, berries, tomatoes and tree fruit as Medical Care Technologies targets crop-specific visual quality inspection applications. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is configuring StrainScan Pro AI vision modules around leafy greens, berries, tomatoes and tree fruit rather than relying on a…
-
Commerce.com Targets $60 Million to $80 Million in Annual Cost Savings
Commerce.com, Inc. (NASDAQ:CMRC) announced a strategic operating plan aimed at generating $60 million to $80 million in annualised cost savings and achieving a non-GAAP operating margin of at least 20% beginning in 2027. The projected savings are equivalent to $0.73 to $0.97 per diluted share based on the company’s share count as of June 30,…
-
Swarmer Shares Rise After Agreement to Acquire Ratel Robotics for Up to $224 Million
Swarmer Inc. (NASDAQ:SWMR) shares rose 4.9% in premarket trading Thursday after the drone autonomy platform company announced a definitive agreement to acquire Ukrainian unmanned ground vehicle manufacturer Ratel Robotics for up to $224 million in cash and stock. The transaction, which includes undisclosed earnout milestones, is subject to customary closing conditions and required legal, regulatory…
-
Tenable Shares Fall 7% After $650 Million Convertible Notes Offering
Tenable Holdings Inc. (NASDAQ:TENB) shares fell 7% in premarket trading Thursday after the exposure management company announced plans to offer $650 million of convertible senior notes due 2031. The notes will be offered through a private placement to qualified institutional buyers. Tenable also plans to give the initial purchasers an option to buy up to…
-
Chemours Shares Rise 6% After $455 Million North Carolina PFAS Settlement
Chemours (NYSE:CC) shares rose 6% on Thursday after the company announced a settlement with the State of North Carolina and 11 local entities covering PFAS-related claims. The agreement resolves litigation concerning PFAS and other historical discharges from the Fayetteville Works facility, as well as claims involving alleged PFAS contamination unrelated to the site, including the…
-
Core Scientific Receives Conditional ERCOT Approvals for Texas Power Capacity
Core Scientific, Inc. (NASDAQ:CORZ) said it received conditional approvals from the Electric Reliability Council of Texas for electrical power capacity across its data centre sites in Denton, Pecos and Hunt, Texas. At the Denton site, 297 megawatts of existing electrical power received conditional approval as “Base Load, Pathway (a),” covering longstanding load energised before March…
-
JetBlue Shares Fall 3% as Higher Revenue Outlook Comes With Increased Costs
JetBlue Airways Corporation (NASDAQ:JBLU) shares fell 3% on Thursday morning after the airline raised its third-quarter 2026 revenue outlook while increasing its forecasts for operating and fuel costs. JetBlue now expects revenue per available seat mile (RASM) to increase 17.0% to 20.0% year over year, compared with its previous forecast of 12.5% to 16.5%. The…